| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $45.03 | $61,916.25 | -1.5% | -3.1% | -48.6% | |
| May 4, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $46.03 | $63,291.25 | -1.5% | -19.5% | -50.0% | |
| Apr 27, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $49.50 | $391,076.86 | -7.9% | -24.7% | -56.5% | |
| Apr 19, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 2,340 | $48.00 | $112,320.00 | -2.5% | -18.0% | -50.8% | |
| Apr 13, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 5,560 | $43.57 | $242,244.20 | -5.9% | -16.1% | -48.4% | |
| Apr 1, 2021 | Parrish Jay | Chief Business Officer | Sale+OE | 6,944 | $51.40 | $356,955.63 | -42.9% | -4.6% | -49.0% | |
| Mar 23, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $53.60 | $423,407.61 | -9.6% | -6.3% | -52.8% | |
| Mar 10, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 2,340 | $48.00 | $112,320.00 | -3.1% | -11.0% | -56.9% | |
| Mar 9, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 5,560 | $44.80 | $249,086.33 | -7.0% | - | - | |
| Mar 1, 2021 | Parrish Jay | Chief Business Officer | Sale+OE | 6,944 | $63.44 | $440,530.83 | -42.9% | - | - |